Thermo Fisher Scientific (TMO) Completes Acquisition of Phadia AB
8/23/2011 10:19:11 AM
More...
|
Phadia AB Launches Phadia 2500 and Phadia 5000 - a Growing Range of Solutions for Allergy and Autoimmunity Diagnostics
8/23/2011 6:15:54 AM
More...
|
Phadia AB Expands its Offering in the Field of Antidrug Antibody (ADA) Testing and Personalized Medicine - Through a Collaboration With Biomonitor
8/22/2011 11:19:32 AM
More...
|
Phadia AB Announces First-Ever Commercial Availability of Peanut Allergen Component Tests
8/16/2011 10:31:29 AM
More...
|
Phadia AB Introduces ImmunoCAP(R) Molecular Allergy and Two New Fully Automated, High Throughput Instrument Platforms at the American Association for Clinical Chemistry Annual Meeting
7/25/2011 10:49:14 AM
More...
|
Dennis M. Flannelly Joins Phadia AB as Head of U.S. Marketing and Strategy
7/19/2011 9:59:08 AM
More...
|
Phadia AB First Company to Receive FDA Clearance of Recombinant Allergen Component Tests
6/20/2011 10:20:36 AM
More...
|
Thermo Fisher Scientific (TMO) Nabs Phadia AB for $3.5 Billion Cash
5/19/2011 7:01:15 AM
More...
|
Phadia Positions the Pharmaceutical Industry to Harness the Power of Personalized Medicine with the Introduction of Innovative Immune Response Diagnostics
3/14/2011 8:45:54 AM
More...
|
Phadia AB Release: New Guidelines Confirm the Significant Role of ImmunoCAP Specific IgE Test in the Diagnosis and Management of Food Allergy
12/8/2010 9:26:33 AM
More...
|
|